Losartan Potassium Tablet, Film Coated
Product Images NDC 71335-1221

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71335-1221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351221)

This is a description of a medicine package for Losartan Potassium 50mg tablet designed to treat high blood pressure. The package contains 30 tablets and can be compared to Cozaar 50mg Tablet. Aurobindo Pharma Limited is the manufacturer and the package should be stored at a room temperature of 20°-25°C (68° T7°F). Additionally, the package warns to keep the medication out of reach of children. The rest of the text is not relevant to the medication description.*

FDA Label Image

Figure1 (Losartan Fig1)

This text seems like a graph or a figure caption, which mentions the names of two medications - Atenolol and Losartan Potassium, and a statistic "Adjusted Risk Reduction" with a percentage of "13%" and the symbol "p=". The numbers from "6" to "66" possibly represent the timeline (in months) of a study. Therefore, this text is not providing any useful description without the graph or figure it refers to.*

FDA Label Image

Figure2 (Losartan Fig2)

This is not-available as the provided text contains only a list of medications and a graph with incomplete information.*

FDA Label Image

Figure 3 (Losartan Fig3)

This is a statistical table showing the primary endpoint events within demographic subgroups. The overall results are presented alongside results for various subgroups based on age, gender, race, and medical history. The meaning of the abbreviations "Py Glrgosds Stoko," "FaaiNon fta," "sty Potsm Aol," and "oo Lo s At Fiesn fene" is not clear and may be the result of errors.*

FDA Label Image

Figure-4 (Losartan Fig4)

This appears to be data related to a clinical trial, and specifically, the comparison between the effects of the drug "Losartan Potassium" and a placebo. The percentage of patients who experienced an "event" is given as 60% for the treatment group and 40% for the control group (placebo). The results suggest a risk reduction of 16.1% in the treatment group compared to the control (placebo) group, and the statistical significance of this change is given as p=0.022.*

FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.